Status:
COMPLETED
Feasibility of Delphi Screener for Cervical Cytology
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Delphi Devices BV
Conditions:
Cervical Neoplasia
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
The aim of this study is to see whether a new self-sampling device, the Delphi Screener (Delphi Devices, Scherpenzeel, Netherlands), can be used for cervical cancer screening. The results using the ne...
Eligibility Criteria
Inclusion
- Valid Pap smear in last 1-3 months obtained at participating clinic
- 18 years or older
- Self-report being able to read in English and/or Spanish
- Willing to sign informed consent
Exclusion
- Used vaginal product (douche, spermicide, antifungal) in last 48 hours
- Last menses started ≤ 4 days prior to enrollment visit
- No uterus / history of hysterectomy
- Self-report currently pregnant
- Self-report currently breastfeeding
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT00702208
Start Date
September 1 2008
End Date
January 1 2010
Last Update
January 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Presbyterian Hospital
New York, New York, United States, 10032